Wealthcraft Capital Inc. is pleased to provide an update with respect to corporate strategy and recent acquisition initiatives.
With the passage of the 2018 Farm Bill, Wealthcraft is refocusing its acquisition strategy towards hemp cultivation, processing and Cannabidiol products. The 2018 Farm Bill changes the entire landscape for the production, marketing, distribution and sale of CBD and other health and wellness-oriented cannabinoids, said Robert Wilson, President of Wealthcraft. We believe that this new law will release restrictions in banking and capital markets and accelerate the growth by opening up all aspects of the CBD supply chain.
Acquisition Update
In response to its focus on CBD, Wealthcraft is pleased to announce that it has entered into letters of intent to acquire a controlling interest in two CBD companies. The first company is a Pennsylvania-based chain of medical clinics that specialize in providing advice and certification for patients seeking cannabinoid-based therapy. Through their nine clinics, approximately 25 wholesale distributors and approximately 25,000 registered patients, the company provides medical cannabis certification services and sells CBD products both online and through their network of clinics.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
By leveraging the patient base of their partner-physicians, the company is able to directly reach a wide segment of the population who suffer from a variety of chronic illnesses, said Robert Wilson, President of Wealthcraft. We believe this is a unique and sustainable model for CBD sales, education and research that has incredible potential as the company undertakes its expansion into four additional states in 2019, Wilson added.
The second letter of intent is with a Colorado-based company which produces and sells a variety of branded CBD products, including sublingual & topical sprays, gel caps, vape-pens, and a recently launched, proprietary metered CBD inhaler. The company has a strategic partnership with one of Colorados largest processing labs, which ensures a continuous supply of consistent quality, full spectrum CBD oil and isolate to meet current and future product demand.
The team at Wealthcraft will be working closely with our Denver CBD partner to launch the new products, expand the companys online reach and fulfill various wholesale channels with product inventory, said Robert Wilson, President of Wealthcraft. With the development and implementation of federal regulations in the CBD industry, we believe that having a well-funded, full scale supplier who is moving towards GMP compliance will be a critical competitive advantage.
Separately, Wealthcraft recently terminated its negotiations that were announced on October 15, 2018, to acquire a controlling interest in a licensed cultivator of cannabis in Las Vegas, Nevada. Pursuant to the terms and conditions of the letter of intent, $100,000 of the deposit has been returned to Wealthcraft.
Date: January 28, 2019
Source: Global Banking & Finance Review
